The Stars Group’s new deal with Fox Sports is a win, says Echelon Wealth

A new deal with FOX Sports is a win for The Stars Group (The Stars Group Stock Quote, Chart TSX:TSGI), says Echelon Wealth Partners analyst Gianluca Tucci, who in a client update on Thursday reiterated his “Buy” rating and C$37.50 target for TGSI.

The announced partnership between TGSI and FOX Sports, a unit of Fox Corporation, will see the launch of online betting platform FOX Bet, which will give TGSI an exclusive license to use FOX Sports trademarks, with the expected launch of FOX Bet coming in the fall of 2019 in time for the NFL season. The deal will see Fox Corp. acquiring 14.4 million newly issued common shares of TSGI, representing 4.99 per cent of the company’s issued and outstanding common shares, at a price of $16.440 per share, the prevailing market price leading up to the start of exclusive negotiations.

Pointing to preliminary estimates that see the US sports betting market as very lucrative, Tucci says,

“We believe this announcement represents a watershed moment with a significant partner whom TSGI can leverage as a very low-cost customer acquisition channel as it carefully places a strategic and significant wager on the US market. We believe this is a significant win for both parties as advertising, television, digital content, and wagering all drive user experience and raise the level of engagement. This type of deal furthers our belief that TSGI is rightfully deserving of a premium multiple relative to peers, which our price target implies.”

Tucci is calling for fiscal 2019 revenue and Adjusted EBITDA of $2,597.1 million and $947.8 million, respectively. (All figures in US dollars unless noted otherwise.) His C$37.50 target represents multiple of fiscal 2019 of 4.9x revenue, 13.5x Adjusted EBITDA and 15.4x P/E, which compares to its Online Gaming Operator comparables average of 2.4x, 9.6x and 15.6x, respectively.

Tucci’s target represented a projected return of 59 per cent at the time of publication.

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: tsgi
Jayson MacLean

Jayson is a writer, researcher and educator with a PhD in political philosophy from the University of Ottawa. His interests range from bioethics and innovations in the health sciences to governance, social justice and the history of ideas.

Recent Posts

Should you buy AMZN? (May, 2024)

Following the company's first quarter results, Roth MKM analyst Rohit Kulkarni has maintained his "Buy" rating on Amazon (Amazon Stock… [Read More]

4 hours ago

These cannabis stocks will benefit most from reclassification

It happened. The move that everyone in the cannabis sector was hoping for came about swiftly on the last day… [Read More]

11 hours ago

Is AMD stock a buy? (May, 2024)

Following the company's first quarter results, Roth MKM analyst Suji Desilva has maintained his "Buy" rating on Advanced Micro Devices… [Read More]

11 hours ago

Is Wolfspeed stock still a buy?

Ahead of the company's third quarter results, Roth MKM analyst Scott Irwin has maintained his "Buy" rating on Wolfspeed (Wolfspeed… [Read More]

12 hours ago

WELL Health inks five-year deal with Microsoft

It's become one of the biggest players in the Canadian healthcare space, now WELL Health (WELL Health Stock Quote, Chart,… [Read More]

1 day ago

Is Thomson Reuters stock a buy right now?

Its stock has made a since last October, but is there more upside left in Thomson Reuters (Thomson Reuters Stock… [Read More]

1 day ago